Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Is Low Among Major European Centres: Results of a Feasibility Questionnaire

被引：68
|
作者：
Burger, Maximilian [1 ]
Mulders, Peter [2 ]
Witjes, Wim [3 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Urol, D-91054 Erlangen, Germany
[2] Radboud Univ Nijmegen, Dept Urol, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands
[3] EAU Cent Res Off, Arnhem, Netherlands
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 05期
关键词：
D O I：
10.1016/j.eururo.2012.01.039
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1070 / 1071
页数：3
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: argument in favor
    David J Gallagher
    Dean F Bajorin
    Nature Clinical Practice Urology, 2008, 5 : 484 - 485
  • [22] Genomic evolution in muscle-invasive bladder cancer resistant to neoadjuvant chemotherapy
    Liu, David
    Abbosh, Philip
    Miao, Diana
    Boyd, Marie Elena
    Hoffman-Censits, Jean H.
    Iyer, Gopa
    Tolaney, Sara M.
    Mouw, Kent William
    Carter, Scott L.
    Bellmunt, Joaquim
    Plimack, Elizabeth R.
    Rosenberg, Jonathan E.
    Van Allen, Eliezer Mendel
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Neoadjuvant chemotherapy for muscle-invasive bladder cancer at the University of Southern California
    Fairey, Adrian Stuart
    Daneshmand, Siamak
    Dorff, Tanya B.
    Dorin, Ryan Paul
    Leiskovsky, Gary
    Quinn, David I.
    Schuckman, Anne
    Cai, Jie
    Miranda, Gus
    Skinner, Eila C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [24] Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer - the Northern Irish Experience
    Johnston, D. I.
    Thompson, R.
    Mitchell, D.
    Shum, L.
    CLINICAL ONCOLOGY, 2023, 35 (02) : E239 - E239
  • [25] Immune correlates of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Ginwala, Rashida
    Macfarlane, Alexander
    Liu, David
    Alpaugh, R. K.
    Xiu, Joanne
    Gatalica, Zoran
    Korn, W. M.
    Van Allen, Eliezer M.
    Campbell, Kerry S.
    Kutikov, Alexander
    Plimack, Elizabeth
    Abbosh, Philip H.
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Miyagi, Hiroko
    Kwenda, Elizabeth
    Ramnaraign, Brian H.
    Chatzkel, Jonathan A.
    Brisbane, Wayne G.
    O'Malley, Padraic
    Crispen, Paul L.
    CANCERS, 2023, 15 (01)
  • [27] Neoadjuvant Chemotherapy: A New Treatment Paradigm for Muscle-Invasive Bladder Cancer
    Herr, Harry W.
    EUROPEAN UROLOGY, 2009, 55 (02) : 303 - 305
  • [28] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: the invisible pink unicorn
    Kan, R. W. M.
    Chan, T. Y.
    Cheng, C. H.
    Li, M. L.
    Lee, K. C.
    Mui, W. H.
    Chu, S. K.
    Man, C. W.
    BJU INTERNATIONAL, 2015, 115 : 8 - 9
  • [29] Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Royce, Trevor J.
    Liu, Yuan
    Milowsky, Matthew, I
    Efstathiou, Jason A.
    Jani, Ashesh B.
    Fischer-Valuck, Benjamin
    Patel, Sagar A.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : 362 - 368
  • [30] Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer
    Gong, Jun
    ONCOLOGY-NEW YORK, 2022, 36 (01): : 30 - 31
12345